Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 13,782 | 14,245 | 16,627 | 12,874 | 9,111 |
| Gross Profit | 13,782 | 14,245 | 16,627 | 12,874 | 9,111 |
| Operating Expenses | 125,259 | 124,241 | 137,434 | 149,321 | 153,881 |
| Operating Income | -111,477 | -109,996 | -120,807 | -136,447 | -144,770 |
| Other Income | 10,153 | 8,741 | 6,478 | 7,549 | 9,058 |
| Pre-tax Income | -101,324 | -101,255 | -114,329 | -128,898 | -135,712 |
| Net Income Continuous | -101,324 | -101,255 | -114,329 | -128,898 | -135,712 |
| Net Income | $-101,324 | $-101,255 | $-114,329 | $-128,898 | $-135,712 |
| EPS Basic Total Ops | -0.92 | -0.98 | -1.10 | -1.27 | -1.34 |
| EPS Basic Continuous Ops | -0.92 | -0.98 | -1.10 | -1.27 | -1.34 |
| EPS Diluted Total Ops | -0.92 | -0.98 | -1.10 | -1.27 | -1.34 |
| EPS Diluted Continuous Ops | -0.92 | -0.98 | -1.10 | -1.27 | -1.34 |
| EPS Diluted Before Non-Recurring Items | -0.92 | -0.99 | -1.10 | -1.24 | -1.34 |
| EBITDA(a) | $-106,541 | $-107,522 | $-118,309 | $-133,881 | $-142,162 |